The BSSG model is potentially at the center of developments in regulation of liver metabolism (liver XR), Gaucher disease (mutations in the glucocerebrosidase gene (GBA1)), and their role in increased risk for α-synuclein aggregation disorders (“synucleinopathies”), which include PD and dementia with Lewy bodies (DLB). This evidence concerns the gene GBA1 and Lewy body dementia.